Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|HER2-Positive Breast Carcinoma|Invasive Breast Carcinoma
Interventions: DRUG: Chemotherapy|PROCEDURE: Computed Tomography|OTHER: Fludeoxyglucose F-18|PROCEDURE: Positron Emission Tomography|PROCEDURE: Surgical Procedure
Sponsor: ECOG-ACRIN Cancer Research Group